• No results found

How to Successfully Complete a Narcotic Tapering with Functional Restoration

N/A
N/A
Protected

Academic year: 2021

Share "How to Successfully Complete a Narcotic Tapering with Functional Restoration"

Copied!
40
0
0

Loading.... (view fulltext now)

Full text

(1)

How to Successfully Complete

a Narcotic Tapering with

Functional Restoration

Fernando Branco M.D. F.A.A.P.M.R.

Medical Director

Rosomoff Comprehensive Rehabilitation Center

and Brucker Biofeedback Center

Miami Jewish Health Systems

(2)

Disclaimer

I am the Medical Director of the

Rosomoff Comprehensive

Rehabilitation Center at MJHS

This Presentations does not

contain off-label and/or

investigational use of drugs or

products

(3)

Conundrums of Chronic Pain

Care:

Avoid Overuse of Narcotics

• Functional Restoration

• Return to Work

• Treat Psychological and Physical

Problems

• Avoid Overuse of Interventional

Treatments

• More Deaths from prescription drugs than

illicit drugs, Fort Lauderdale had more Pain

Clinics than McDonald’s

(4)

P A I N

• Can’t see it

• Can’t measure it

• Can’t diagnose it on x-ray or MRI

• 75% of general population will have

abnormal MRIs – bulging or herniated

discs or narrowing…..and NO PAIN.

(5)
(6)

Drug Addict? Drug Abuse?

Excessive use of a drug for purposes for which

it is not medically intended.

(7)

The Risk of Addiction

Published rates of abuse

and/or addiction in chronic

pain populations are 3-19%

Known risk factors for

addiction to any substance

are good predictors for

opioid abuse

Ives et al 2006 Reid et al 2002 Michna et al 2004

Akbik et al 2006

1.

Past cocaine use, h/o of

alcohol or cannabis use

2.

Lifetime history of substance

use disorder

3.

Family history of substance

abuse, history of legal

problems and drug and

alcohol abuse

4.

Tobacco dependence

5.

History of severe depression

(8)

Addiction is

• A primary, chronic,

neurobiological

disease with genetic,

psychosocial and

environmental factors

influencing its

development and

manifestations

Savage SR et al JPain Symptom Manage 2003

• A clinical syndrome:

– Loss of control

– Compulsive use

– Continued use

despite harm

– Craving

(9)

Pseudoaddiction

Opiophobia

Overestimate potency

and duration of action

Fear of being scammed

Fear of addiction

potential

Morgan J 1985 Smith 1989

(10)

Yellow Flags

• Complaints of more medications needed

• Drug hoarding

• Requesting specific pain medications

• Openly acquiring similar medications from other providers

• Occasional unsanctioned dose escalation

• Nonadherence to other recommendations for pain therapy

(11)

Red Flags

• Deterioration in functioning at work and socially

• Illegal activities – selling, forging, buying from

nonmedical sources

• Injecting and snorting medication

• Multiple episodes of “lost” or “stolen” scripts

• Resistance to change therapy despite adverse

effects

• Refusal to comply with random drug screens

• Concurrent abuse of alcohol or illicit drugs

• Use of multiple physicians and pharmacies

(12)

Narcotic Cycle

Patients need higher doses to achieve results =

TOLERANCE

Eventually lack of pain relief may lead to steady

increases in amount and types of pain medication

Long term use of narcotics leads to “OPIOD

INDUCED ABNORMAL PAIN SENSITIVITY”

(13)

Narcotics

Eliminate production of your own body’s

ENDORPHINS

Shut the endorphin system down

Lead to HYPERalgesia and HYPERsensitivity

to pain

(14)

Journal of Opioid

Management

Significant pain reduction in chronic pain patients

after detoxification from high-dose opioids” –

Sept/Oct 2006

21 of the 23 patients showed marked decrease in

pain following tapering from narcotics!!

(15)

Publications

Opioid-induced hyperalgesia: pathophysiology &

clinical implications: Journal of Opioid

Management 2008

Opioid induced abnormal pain sensitivity – Current

Pain Headache Report 2006

Adverse effects of chronic opioid therapy for chronic

musculoskeletal pain – National Rev of

Rheumatology 2010

Hyperalgesia in opioid-managed chronic pain and

opioid-dependent patients – Journal of Pain 2009

(16)

SERIOUS SIDE EFFECTS

Narcotics slow down the action of the bowel / intestines

resulting in severe constipation

almost always requiring another medication to help

relieve this symptom

Urinary retention – inability to empty bladder

most often in males

Hypogonadism – decreased sex drive, erectile dysfunction –

often requires need for additional meds

(17)

What is the

Solution?

(18)

MYOFASCIAL SYNDROME

• Sciatica

• Neuropathy

• Sinus problems / dental pain

• Carpal Tunnel

• Migraine

Leads to misdiagnosis & incorrect tx

(19)
(20)
(21)

Goals of Treatment

— Improve quality of life

— Restore optimum levels of function

— Reduce or eliminate pain

— Reduce or eliminate addictive pain medications

— Enable become independent of the healthcare system

(22)

EFFECTIVE TREATMENT

• Return to the basics:

– Physical and Psychological Rehabilitation

– Physical Medicine

– True Multidisciplinary Approach

What is the definition of insanity?

"The definition of insanity is doing the same thing over

and over and expecting a different result.“

(23)

Outpatient Weaning

• Office

• Outpatient drug “detox” program

• Outpatient Comprehensive Pain Management Program (community weaning)

Patient Characteristics

• On lower opioid dose, simpler medication plan (1-2 meds), more gradual wean • Motivated

• Low to medium psychosocial issues • Community social support for plan

Weaning Process

• Speed of weaning: dose decrease by 20-25% every 10-14 days

• Monitoring: Urinary drug screen, pain behaviors, drug use and seeking, functional status

• Support: Meds for withdrawal (temporary), physical rehabilitation (functional approach), follow-up every 1-2 weeks, but available by phone daily, proactive check-in; cognitive behavioral approach

Case Management

• Red flags: Increased pain complaints: ”Can’t bear it,” “Carrier did not approve X,” “Equipment did not arrive,” pharmacy issues, “worrisome” symptoms.

• Actions: contact injured worker in person if possible, review treatment recommendations and symptoms

management, contact treating team, return to provider if not able to assure compliance, do not approve increase in meds or new diagnostic evaluations or treatment changes unless recommended by current treatment team; disallow return to prior prescribers.

Setting s

(24)

Inpatient Weaning

• Residential drug “detox” program

• Weaning as part of Comprehensive Pain Management Program* • Rapid detox (addressed later)

Patient Characteristics

• On high doses of opioids and/or complex drug regimens or needs more rapid detox • Not motivated or resistant to weaning

• Medium to high psychosocial issues; history of psychiatric diagnosis, prior failed detox • Poor community social support for plan

Weaning Process

• Speed of weaning: dose decrease by 20-25% every 3 days

• Monitoring: Urinary drug screen, pain behaviors, drug use and seeking, functional status

• Support: Meds for withdrawal (temporary), physical rehabilitation (functional approach), follow-up every day, available by phone daily, proactive check-in, onsite problem resolution; aggressive physical rehabilitation to separate physical from drug issues; multiple modalities to treat withdrawal

Case Management

• Red flags: Increased pain complaints, limited participation, desire to quit program, family support not adequate or detrimental, core beliefs unchanged, anger at carrier, multiple addiction issues. Post-discharge issues.

• Actions: Family engagement, clear-cut discharge pre-planning regarding pharmacy limitation, approved physicians, day-to-day problem resolution using providers from pain program. Urine drug screens. Onsite psychological support, cognitive behavioral approach.

Setting s

(25)

Replacement Therapies

• Outpatient: bridge to detoxification • Methadone, Buprenorphine products

Patient Characteristics

• On high doses of opioids predominantly

• Indicated for addiction; very limited as a pain “solution”

• Motivated wean off current meds, agrees to terms of process or case who will not wean, out of control • Low to medium psychosocial issues

• Good community social support for plan

Weaning Process

• Speed of weaning: induction requires care, but is relatively quick; subsequent taper is slow • Monitoring: Urinary drug screen, pain behaviors, drug use and seeking, functional status • Support: Functional restoration, cognitive behavioral therapies, support groups (AA, NA)

Case Management

• Red flags: Lower risk of abuse if no other meds prescribed; pain complaints likely to continue. Patient may advocate to go back on pain medications. Control.

• Actions: Consider inpatient or outpatient detoxification.

Setting s

(26)

■ Indications:

Few, if any. Low doses of narcotics.

■ Claims:

Painless, cheaper, safe.

■ Realities:

Very risky (high death rate) from “coma” detoxification, does not treat root

of the problem, severe withdrawals and craving on discharge without any support.

■ Risks:

Death, suicide due to severe withdrawals, pain not addressed, immediately

resuming use of narcotics.

■ Ideal candidate:

Maybe patient with no addiction history who medically needs to be

off meds ASAP.

■ The data supporting the safety and effectiveness of opioid antagonist agent

detoxification under sedation or general anesthesia is limited, and adequate safety

has not been established. Given that the adverse events are potentially life

threatening, the value of antagonist-induced withdrawal under heavy sedation or

anesthesia is not supported.

Rapid Detoxification

(27)

Possible

Symptoms of Withdrawal

— Flu-like aches and pains

— Sweating, tearing, runny nose

— Chills, flushing

— Goose bumps

— Ants crawling on your skin

— Loss of appetite

— Headache

— Anxiety

— Restlessness / Restless legs

— Severe insomnia

(28)

PHYSICAL

THERAPY

(29)

S

T

R

E

T

C

H

I

N

G

PASSIVE

ACTIVE

(30)

HEAT

(31)
(32)

PAIN RELIEF AIDS

(33)

OCCUPATIONAL THERAPY

P

R

E

V

E

N

T

I

N

J

U

R

Y

(34)

OCCUPATIONAL

THERAPY

POSTURE

BALANCE

(35)

ERGONOMICS

• Human Performance Testing

• Workplace Design / Analysis

• Job Simulation

(36)
(37)

BIOFEEDBACK THERAPY

• Relaxation

• Re-education

• Body Mechanics

• Posture

(38)

MOTOR DYSFUNCTION EVALUATION

(39)

PSYCHOLOGY SERVICES

• Evaluation

• Manage behavioral crises.

• Support during Tx

• Individual, group, family

• Self Hypnosis Training

(40)

References

Related documents